101 related articles for article (PubMed ID: 7242318)
1. [Comparative invasive examination of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in chronic coronary insufficiency].
Bödigheimer K; Nowak FG; Delius W
Med Welt; 1981 Apr; 32(14A):543-7. PubMed ID: 7242318
[No Abstract] [Full Text] [Related]
2. [Clinical use of slow-release isosorbide-5-mononitrate in cardiac insufficiency].
Caponnetto S; Canale C; Terrachini V; Masperone MA
Cardiologia; 1987 Nov; 32(11):1303-9. PubMed ID: 3447704
[No Abstract] [Full Text] [Related]
3. Acute and chronic use of isosorbide 5-mononitrate in patients with heart failure.
Stephens JD; Marks C; Woodings D; Vandenburg MJ
Cardiology; 1987; 74 Suppl 1():69-71. PubMed ID: 3607807
[No Abstract] [Full Text] [Related]
4. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
Reifart N; Reifart F; Kaltenbach M; Bussmann WD
Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
[No Abstract] [Full Text] [Related]
5. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
Smolarz A; Seeliger S; Glocke M
Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
[No Abstract] [Full Text] [Related]
6. [Effect of isosorbide-5-mononitrate (IS-5-MN) on left ventricular hemodynamics].
Mehmel HC; Ruffmann K; Schwarz F; Manthey J; Kübler W
Med Welt; 1981 Apr; 32(14A):527-9. PubMed ID: 7242314
[No Abstract] [Full Text] [Related]
7. Haemodynamic effects of intravenous isosorbide-5-mononitrate in acute and chronic left heart failure of ischaemic aetiology.
Rabinowitz B; Katz A; Shotan A; Chouraqui P; Neufeld HN
Eur Heart J; 1988 Jan; 9 Suppl A():175-80. PubMed ID: 3409914
[TBL] [Abstract][Full Text] [Related]
8. [Hemodynamic effect of 20 mg and 50 mg of 5-isosorbide mononitrate in acute and chronic therapy].
Jansen W; Osterspey A; Fuchs M; Tauchert M; Schell U; Weste S; Hombach V
Med Welt; 1982 Dec; 33(48):1756-62. PubMed ID: 6818416
[No Abstract] [Full Text] [Related]
9. [Comparative evaluation of the effect of phentolamine and nitrosorbide on the central hemodynamics of children with chronic heart failure].
Serbin VI; Ivanov AP; Loginova IF; Borisov BE
Pediatriia; 1986 Sep; (9):72-3. PubMed ID: 3786080
[No Abstract] [Full Text] [Related]
10. Oral isosorbide-5-mononitrate: pharmacokinetics and clinical efficacy.
Kanto JH
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):129-35. PubMed ID: 3557738
[TBL] [Abstract][Full Text] [Related]
11. [Hemodynamic effect, effect duration and pharmacokinetics of 80 mg of isosorbide-5-mononitrate in acute myocardial infarct].
Reifart N; Bussmann WD; Schirmer M; Kaltenbach M
Med Welt; 1981 Apr; 32(14A):540-2. PubMed ID: 7242317
[No Abstract] [Full Text] [Related]
12. [Hemodynamic changes at rest and during stress following isosorbide-5-mononitrate therapy in patients with coronary disease].
Isbary J; Doering W; Wauer B; Greding H; König E
Med Welt; 1981 Apr; 32(14A):530-4. PubMed ID: 7242315
[No Abstract] [Full Text] [Related]
13. [Hemodynamic effects of isosorbide-5-mononitrate in ischemic cardiopathy].
Russo G; Tolaro S; Monaco O; Greco G; Grassi R; Monaco A; Calvi V; Felis S; Tamburino C; Giuffrida G
Cardiologia; 1988 Mar; 33(3):291-5. PubMed ID: 3401892
[No Abstract] [Full Text] [Related]
14. [Long-term treatment of chronic congestive heart failure with oral isosorbide dinitrate and phenotoline (author's transl)].
Lemke R; Lippok R; Kaltenbach M; Bussmann WD
Z Kardiol; 1979 Feb; 68(2):82-8. PubMed ID: 106563
[No Abstract] [Full Text] [Related]
15. [Trinitroglycerin ointment and oral isosorbide dinitrate: comparison of the hemodynamic effects induced in acute myocardial infarct with left ventricular insufficiency].
Mauri F; Mafrici A; Azzollini M; Maggiulli G; Domenichini R
Boll Soc Ital Cardiol; 1981; 26(10):1157-9. PubMed ID: 6817766
[No Abstract] [Full Text] [Related]
16. Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure.
Franciosa JA; Cohn JN
Am J Cardiol; 1980 Mar; 45(3):648-54. PubMed ID: 6766653
[No Abstract] [Full Text] [Related]
17. [Clinical and hemodynamic evaluation of isosorbide dinitrate therapy in heart failure (author's transl)].
Miranda V; Saavedra J; Opazo JA; Stockins B; Contreras M; Lanas F
Rev Med Chil; 1979 Aug; 107(8):721-3. PubMed ID: 545565
[No Abstract] [Full Text] [Related]
18. [Hemodynamic effects of isosorbide dinitrate (Isomack Retard capsules) in chronic heart failure].
Stejfa M; Vítovec J; Blaha M; Roubalík P
Vnitr Lek; 1988 Aug; 34(8):772-6. PubMed ID: 3176367
[No Abstract] [Full Text] [Related]
19. [Rapid attenuation of effects of isosorbide dinitrate during long-term treatment of chronic congestive heart failure].
Blasini R; Froer KL; Blümel G; Rudolph W
Herz; 1982 Aug; 7(4):250-8. PubMed ID: 6813211
[No Abstract] [Full Text] [Related]
20. [Hemodynamic effects of oral dihydralazine and sublingual isosorbide dinitrate, alone and in combination in chronic heart failure].
Page A; Larnaudie B; Pic A; Videau P; Besse P
Arch Mal Coeur Vaiss; 1979 Dec; 72(12):1367-75. PubMed ID: 120154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
